About

At Valence Labs / Recursion, I led a team developing virtual cells, AI models that predict and explain how cells respond to chemical and genetic perturbations, with the goal of accelerating the discovery of new therapies. I also built the company's molecular design and AI platform, spanning generative drug design, property prediction, and multi-objective optimization. I also led the development of one of the earliest agentic AI systems for drug discovery.

I completed my PhD in Computational Biology at Université de Montréal, where I studied genome evolution. I also teach AI courses for medical professionals at McGill University and Université d'Abomey-Calavi in Benin.

Beyond research, I invest in and help build early-stage ventures across techbio, healthcare, clean technology, and other emerging fields. I grew up in Benin and remain actively involved in supporting entrepreneurship and local investment there. More about this work can be found on the other projects page.